Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Mcgirr Insider Profile
4 Followers
David Mcgirr, Director at Insmed, holds 3.00K shares in Rhythm Pharmaceuticals (Ticker: RYTM), holds 96.67K shares in X4 Pharmaceuticals (Ticker: XFOR), holds 98.92K shares in Insmed (Ticker: INSM).
David Mcgirr has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Mcgirr holds in companies
Most Profitable Insider Trade
Stock:
Sorrento Tech Inc
(ROKA)
(ROKA)
Rating:Informative Buy
Date:Nov 17, 2014 - Nov 17, 2015
Return:-66.60%
The most profitable trade made by David Mcgirr
David Mcgirr's Trading History
Insmed
May 15, 2024
Director
Uninformative Buy
―
$7.33M
X4 Pharmaceuticals
Jun 11, 2024
Director
Uninformative Buy
―
$32.38K
Rhythm Pharmaceuticals
Jun 25, 2024
Director
Uninformative Buy
125.61K
$179.76K
VYNE Therapeutics
―
Director
―
―
Sorrento Tech Inc
Nov 17, 2014
―
Informative Buy
179.89K
$32.50K
Relypsa Inc
Jun 23, 2016
―
Uninformative Buy
―
$119.71K
Cubist Pharma
Feb 20, 2013
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see David Mcgirr's performance on stock
You May Also Like
David Mcgirr insider profile FAQ
What is the percentage of profitable transactions made by David Mcgirr?
The percentage of profitable transactions made by David Mcgirr is ―.
What is the average return per transaction made by David Mcgirr?
The average return per transaction made by David Mcgirr is ―.
What stocks does David Mcgirr hold?
David Mcgirr holds: INSM, XFOR, RYTM, VYNE, ROKA, RLYP, CBST stocks.
What was David Mcgirr’s latest transaction?
David Mcgirr latest transaction was an Uninformative Buy of $125.61K.
What was David Mcgirr's most profitable transaction?
David Mcgirr’s most profitable transaction was an Informative Buy of ROKA stock on November 17, 2014. The return on the trade was -66.60%.
What is David Mcgirr's role in Insmed?
David Mcgirr's role in Insmed is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.